Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tested product | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| F17464 | Drug | Single dose |
|
| Measure | Description | Time Frame |
|---|---|---|
| Binding rate to cerebral receptors | by brain imaging | up to 29 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York | New York | United States |
Not provided
| ID | Term |
|---|---|
| C000717801 | dopamine D3 receptor antagonist F17464 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided